Suppr超能文献

广泛的医疗保健利用和酒精性肝炎早期肝移植计划的成本。

Extensive Health Care Utilization and Costs of an Early Liver Transplantation Program for Alcoholic Hepatitis.

机构信息

Recanati/Miller Transplantation Institute, Division of Liver Diseases, Department of Medicine Icahn School of Medicine at Mount Sinai New York NY Recanati/Miller Transplantation Institute, Division of Abdominal Transplantation, Department of Surgery Icahn School of Medicine at Mount Sinai New York NY Division of Liver Diseases, Department of Medicine Icahn School of Medicine at Mount Sinai New York NY Recanati/Miller Transplantation Institute New York NY Department of Psychiatry The Mount Sinai Medical Center New York NY.

出版信息

Liver Transpl. 2022 Jan;28(1):27-38. doi: 10.1002/lt.26215. Epub 2021 Aug 7.

Abstract

Early liver transplantation (LT) for severe alcoholic hepatitis (AH) is a rescue therapy for highly selected patients with favorable psychosocial profiles not responding to medical therapy. Given the expected increase of AH candidate referrals requiring complex care and comprehensive evaluations, increased workload and cost might be expected from implementing an early LT program for AH but have not been determined. Some centers may also view AH as a strategy to expeditiously increase LT volume and economic viability. The aim of this study was to determine the health care use and costs of an early LT program for AH. Analyses of prospective databases of AH, interhospital transfers, and the hospital accounting system at a single center were performed from July 2011 to July 2016. For 5 years, 193 patients with severe AH were evaluated at our center: 143 newly referred transfers and 50 direct admissions. Annual increases of 13% led to 2 to 3 AH transfers/month and AH becoming the top reason for transfer. There were 169 (88%) nonresponders who underwent psychosocial evaluations; 15 (9%) underwent early LT. The median cost of early LT was $297,422, which was highly correlated with length of stay (r = 0.83; P < 0.001). Total net revenue of the program from LT admission to 90 days after LT was -$630,305 (-5.0% revenue), which was inversely correlated with MELD score (r = -0.70; P = 0.004) and yielded lower revenue than a contemporaneous LT program for acute-on-chronic liver failure (ACLF; $118,168; 1.4% revenue; P = 0.001). The health care use and costs of an early LT program for AH are extensive and lifesaving with marginally negative net revenue. Significantly increasing care of severe AH patients over 5 years resulted in increased LT volume, but at a lower rate than ACLF, and without improving economic outcomes due to high MELD and prolonged length of stay.

摘要

早期肝移植(LT)治疗严重酒精性肝炎(AH)是一种针对经药物治疗无反应且具有良好社会心理特征的高度选择患者的抢救疗法。鉴于需要复杂护理和综合评估的 AH 候选者转诊人数预计会增加,实施早期 LT 治疗 AH 方案可能会导致工作量和成本增加,但目前尚未确定。一些中心可能还将 AH 视为增加 LT 量和经济可行性的一种策略。本研究旨在确定早期 LT 治疗 AH 方案的医疗保健使用和成本。对单一中心的 AH 前瞻性数据库、院内转院和医院会计系统进行了分析,时间从 2011 年 7 月至 2016 年 7 月。5 年来,我们中心共评估了 193 例严重 AH 患者:143 例为新转诊患者,50 例为直接入院患者。每年增加 13%导致每月有 2-3 例 AH 转院,AH 成为转院的首要原因。169 例(88%)非应答者接受了社会心理评估;15 例(9%)接受了早期 LT。早期 LT 的中位费用为 297422 美元,与住院时间高度相关(r=0.83;P<0.001)。从 LT 入院到 LT 后 90 天的程序总收入为-630305 美元(-5.0%的收入),与 MELD 评分呈负相关(r=-0.70;P=0.004),收入低于同期慢性肝衰竭急性加重(ACLF)的 LT 方案(118168 美元;1.4%的收入;P=0.001)。早期 LT 治疗 AH 的医疗保健使用和成本广泛且挽救生命,但净收入略有负值。5 年来,严重 AH 患者的护理显著增加,导致 LT 量增加,但增加速度低于 ACLF,并且由于 MELD 较高和住院时间延长,并未改善经济结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验